Clinical Trial Update: Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

View source ↗

Summary

The University of Kansas Medical Center is conducting a longitudinal biorepository for bladder cancer to support development of novel therapeutics and biomarker…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Bladder Cancer | Status: RECRUITING